HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Anesthesiology & Pain Medicine
RCT
Feedback-regulated background infusion reduces postoperative nausea and vomiting in laparoscopic myomectomy patients.
Smart pump cuts nausea after surgery without hurting pain control
This randomized controlled trial enrolled 132 patients undergoing laparoscopic myomectomy. Feedback-regulated background infusion significan…
A new smart pain pump adjusts medicine automatically to cut nausea after surgery while keeping pain relief strong for patients who need it m…
Apr 29, 2026
Drug Pipeline
Meta-analysis
Systematic review and meta-analysis on oliceridine versus morphine for postoperative nausea and vomiting.
Oliceridine at low doses reduces nausea and vomiting after surgery compared with morphine
This systematic review and meta-analysis of 1,767 patients found that oliceridine significantly reduced postoperative nausea and vomiting co…
A meta-analysis shows oliceridine lowers nausea and vomiting after anesthesia compared to morphine, with fewer side effects at specific dose…
Frontiers
Apr 24, 2026
Anesthesiology & Pain Medicine
Meta-analysis
Meta-analysis finds TEAS reduces PONV after laparoscopic surgery
A Simple Patch May Stop Nausea After Surgery
This meta-analysis of 6271 patients found that transcutaneous electrical acupoint stimulation (TEAS) reduced the incidence of postoperative …
This research shows a non-drug option could make recovery from keyhole surgery much more comfortable.
Apr 23, 2026
Anesthesiology & Pain Medicine
RCT
TEAS at PC6 during hepatectomy does not reduce PONV incidence within 24 hours
Surgery Nausea: Why a Common Pain Relief Method May Not Help After All
In this randomized controlled trial of 161 patients undergoing elective hepatectomy, intraoperative transcutaneous electrical acupoint stimu…
A popular non-drug technique used during major liver surgery did not reduce postoperative nausea and vomiting in patients already receiving …
Apr 20, 2026
Oncology
FDA Approval
FDA Approves Ondansetron Injection, USP (ondansetron hydrochloride) for Prevention of Chemotherapy-Induced and Postoperative Nausea/Vomiting
FDA approves a new preservative-free injection to prevent nausea and vomiting from chemotherapy and surgery.
FDA approved ondansetron injection for prevention of nausea/vomiting associated with emetogenic cancer chemotherapy and postoperative nausea…
FDA approves a new preservative-free injection to prevent nausea and vomiting from chemotherapy and surgery.
FDA
Apr 10, 2026